Research progress and design optimization of CAR‐T therapy for pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant cancer with limited treatment options. Chimeric antigen receptor T cells (CAR‐T) are genetically engineered T cells that can specifically kill tumor cells without major histocompatibility complex restriction. Encouraging progress in CAR‐T...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tianjiao, Li, Hao, Li, Shuo, Xu, Shuaishuai, Zhang, Wuhu, Gao, Heli, Xu, Huaxiang, Wu, Chuntao, Wang, Wenquan, Yu, Xianjun, Liu, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718528/
https://www.ncbi.nlm.nih.gov/pubmed/31339230
http://dx.doi.org/10.1002/cam4.2430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718528/
https://www.ncbi.nlm.nih.gov/pubmed/31339230
http://dx.doi.org/10.1002/cam4.2430

Ejemplares similares